[复杂的皮肤雷什曼病与骨参与]
G A Hübner1, W Prüßmann2, N Jossifov2
1Klinik für Dermatologie, Allergologie und Venerologie (Hautklinik), UKSH Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland. Gisela.Huebner@uksh.de.
Dermatologie (Heidelberg, Germany)
|June 25, 2024
概括
这份病例报告详细介绍了一种罕见的骨感染病例,该病例发生在一个免疫功能低下的患者身上,这种骨感染病例是由Leishmania infantum引起的. 早期诊断和用米尔特福辛治疗对于管理皮肤传染外皮传播的皮肤莱什曼病至关重要.
科学领域:
- 传染性疾病 传染性疾病
- 寄生虫学的寄生虫学
- 皮肤病学 皮肤病学
背景情况:
- 皮肤莱什曼病 (CL) 是一种主要影响皮肤的寄生病.
- 免疫功能低下的个体有更高的传播和非典型的CL呈现的风险.
- 婴儿莱什马尼亚是已知的内脏莱什马尼亚病的原因,并可能导致CL.
研究的目的:
- 报告第一个由婴儿莱什曼尼亚引起的皮肤莱什曼尼亚病的骨干干扰病例.
- 突出强调在患有CL的免疫功能低下患者中考虑外皮表现的重要性.
主要方法:
- 使用聚合酶链反应 (PCR) 测试证实了Leishmania (L.) 婴儿感染的诊断.
- 用于PCR分析的样本来自皮肤病变和骨组织.
- 进行了临床评估和治疗监测.
主要成果:
- 在一个免疫功能低下的患者身上,发现了左小脚的一个独特的骨.
- PCR测试证实了Leishmania (L.) 婴儿感染在皮肤和骨组织中.
- 患者获得了成功的米尔特福辛治疗.
结论:
- 这是首次报告由于婴儿莱什马尼亚导致的CL骨参与的病例.
- 在被诊断患有CL的免疫受损患者中,应积极排除皮肤外表现,包括骨参与.
- 米尔特福辛是一种有效的治疗选择,用于复杂的CL与骨干参与.
更多相关视频
06:57In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
Published on: February 20, 2020
8.2K
10:01Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites
Published on: March 16, 2018
10.5K
相关概念视频
Skin Diseases and Disorders
3.8K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.8K
Pulmonary Tuberculosis III
321
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
321
